Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by fossi_2002on Jan 08, 2024 8:36am
135 Views
Post# 35815266

fossi doesn't want people to talk about it.

fossi doesn't want people to talk about it.PROPH... How many months, even years, have you been telling us about the fantastic views from Ceapro every day?

You have completely ignored our criticism of the quarterly results, of Symrise, of the constant failure to meet timetables in the development of the pipeline.

The only thing that has increased during this time is the salaries of Gilles and Ronnie.

We shareholders have been left behind in every respect.

Now suddenly the turnaround. Our cash situation is deteriorating, the Avenanthramide trial is costing money and the PGX facilities are also costing a lot of money. - And dear Fossi is supposed to develop an alternative plan instead of a merger.

Has anyone ever heard a stupider joke?

Gilles was apparently unable to develop a business plan for CZO. This business plan certainly didn't include a merger a few months ago.

Now the alarm bells are ringing!
Who kept telling us about the great deal with Symrise? That was simply a lie!
Who told us that the decline in orders in the core business was only temporary, was that also a lie?

Your fantasy about the pipeline is completely implausible, but since it cannot be proven, you propagate it every day.

Of course, the statements of Gilles and Ronnie have to serve as proof.

Just as bad is your citing of the AEZS price target of US$15 by Wainwright. If they cut the price target to US$5 tomorrow, as has happened several times, who cares.



<< Previous
Bullboard Posts
Next >>